My Medical Gateway News

A major investigation by The Economist reveals that hospitals across Britain, Europe, North America and Australia remain trapped in a post-pandemic healthcare crisis defined by growing waiting lists, overcrowded emergency departments and worsening patient outcomes. For UK patients facing NHS delays that are likely closer to 9 million treatment pathways rather than the official 7.2 million figure, the findings reinforce why demand for faster, affordable private treatment abroad is rising sharply – with MMG research showing a potential UK addressable market of 5.4 million adults actively open to European healthcare solutions. 

For years, healthcare systems promised the disruption caused by Covid-19 would eventually stabilise, waiting lists would reduce and capacity would recover. Normality would return.

A major investigation published by The Economist in April 2026 suggests exactly the opposite has happened. In an article titled “Hospitals are stuck in a deadly doom loop”, the publication concluded that healthcare systems across Britain, Europe, North America and Australia never truly recovered from the pandemic. 

Instead, hospitals are now trapped in a cycle of worsening delays, declining productivity, rising patient complexity and growing operational pressure.

For UK patients currently waiting months – and often years – for diagnostics, orthopaedic surgery, spinal procedures or specialist treatment, the implications are enormous.

The report highlights that emergency departments across developed nations are now under unprecedented strain. In England, more than a quarter of patients spend over four hours in A&E, roughly double pre-pandemic levels. Nearly one in ten emergency admissions waited more than 12 hours for a hospital bed after the decision to admit them had already been made. The Royal College of Emergency Medicine estimates that trolley waits contributed to almost 5,000 avoidable deaths in British hospitals during one summer period alone. 

The pressure is not confined to Britain. In Australia, almost half of ambulance arrivals wait more than 30 minutes outside emergency departments before patients can even enter hospital buildings. In Canada, record numbers of patients are now leaving emergency departments before ever being seen. France’s main hospital union has warned of an “unprecedented deterioration” in healthcare access. 

Perhaps most strikingly, these failures are occurring despite record healthcare spending and staffing increases.

OECD healthcare spending has risen to nearly 10% of GDP. NHS staffing has increased dramatically, with England’s NHS workforce growing by 25% since 2019 to approximately 1.4 million employees. American hospitals added almost 140,000 jobs last year alone. Yet despite more funding and more staff, productivity remains below pre-pandemic levels across many healthcare systems. 

The Economist identifies a dangerous structural cycle driving the crisis. Longer waits leave patients sicker, sicker patients require more complex treatment, more complex treatment consumes greater hospital capacity, reduced capacity creates even longer waits. The cycle then repeats. 

Across OECD countries, elective surgery activity fell by 19% during the pandemic and has never fully recovered. In Britain, 2.8 million patients in January 2026 had already waited more than 18 weeks for treatment, compared with just 570,000 in 2019. 

This is increasingly changing how UK patients think about healthcare itself.  New independent market research conducted for MMG by SONDER in July 2025 found that 81% of UK adults believe NHS waiting lists are now “simply too long”. Nearly half of UK adults say they would use private healthcare if they could afford it. 

The research also identified a major shift in attitudes toward treatment abroad. According to the study, 17% of UK adults are currently planning a relevant surgical procedure. Of those patients, 59% said they would consider using a medical gateway platform enabling fast and affordable treatment at accredited hospitals in the European Union. This creates an estimated UK addressable market of approximately 5.4 million adults. 

Importantly, the demand is not being driven purely by price. The strongest drivers identified by SONDER’s research were speed, ease of access and quality of care. Eighty-three percent of the addressable market said guaranteed faster treatment was a key attraction. Eighty-two percent agreed NHS waiting lists are now simply too long. Seventy-seven percent believed they would receive a better healthcare experience and 67% agreed there is better private healthcare available in many European countries than in the UK. 

The profile of these patients is also revealing. The strongest interest comes from working-age adults between approximately 25 and 65, particularly patients needing orthopaedic surgery and corrective procedures. Many are physically active professionals who say they “cannot afford to be out of action for long”. The research found strong over-indexing among people working in finance, technology, construction and physically demanding professions. 

In other words, these are not patients seeking luxury healthcare experiences. They are people trying to regain mobility, reduce pain, return to work and restore normality to their lives.

The research also highlights growing public confidence in European healthcare quality. Forty-one percent of MMG’s addressable audience believe healthcare in the European Union is better than in the UK, while many respondents referenced positive experiences in countries such as Germany and Spain. 

For many patients, the conversation has fundamentally changed. This is no longer simply about NHS reform or temporary backlog management. Patients increasingly recognise that structural healthcare pressures are unlikely to disappear quickly. Ageing populations, higher patient complexity and ongoing workforce strain are creating a long-term challenge that affects healthcare systems across the developed world simultaneously.

As a result, affordable private healthcare abroad is becoming an increasingly mainstream solution for UK patients seeking consultant-led care, fixed-price surgery packages, faster diagnostics and treatment within weeks rather than months or years.

The pandemic may have exposed the weaknesses in global healthcare systems. But for millions of patients now stuck waiting in pain, it is also accelerating a major shift in how people access healthcare itself.